Skip to main content
Signal8

GOEDDEL DAVID V

SEC insider (Form 3/4/5 filer). CIK 0001182464. Director & 10% Owner at Tenaya Therapeutics, Inc. (TNYA). 3 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies GOEDDEL DAVID V has filed insider reports for

  • Tenaya Therapeutics, Inc. (TNYA): Director, 10% Owner
GOEDDEL DAVID V profile photo

GOEDDEL DAVID V

CIK: 0001182464

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tenaya Therapeutics, Inc. logo
TNYA

Tenaya Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    May 29, 2025
    Award

    Stock Option (Right to buy)

    Direct
    107.4K shares-
  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    Mar 5, 2025
    Purchase
    Indirect
    35.7M shares at avg. $0.70$25.0M
  • Tenaya Therapeutics, Inc. logo
    TNYA

    Tenaya Therapeutics, Inc.

    Oct 18, 2024
    Award

    Stock Option (Right to buy)

    Direct
    34K shares-

1-3 of 3